Cosmos Health Inc. (COSM)
(Delayed Data from NSDQ)
$1.09 USD
-0.01 (-0.97%)
Updated Aug 14, 2024 03:47 PM ET
After-Market: $1.07 -0.02 (-1.77%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Price, Consensus and EPS Surprise
COSM 1.09 -0.01(-0.97%)
Will COSM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for COSM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for COSM
MediWound (MDWD) Reports Q2 Loss, Lags Revenue Estimates
Durect (DRRX) Reports Q2 Loss, Lags Revenue Estimates
COSM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Recursion Pharmaceuticals (RXRX) Reports Q2 Loss, Tops Revenue Estimates
MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates
Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops Revenue Estimates
Other News for COSM
Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market
Cosmos Health reports FY23 EPS ($2.15) vs. ($33.16) last year
Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share
Cosmos Health signs distribution agreement with Sky Premium Life Food supplements
Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland